Connection

Janardan Pandey to Scleroderma, Systemic

Back to Details
This is a "connection" page, showing publications Janardan Pandey has written about Scleroderma, Systemic.
Janardan Pandey
Connection Strength
1.787
Scleroderma, Systemic
  1. Antibodies to human cytomegalovirus protein UL83 in systemic sclerosis. Clin Exp Rheumatol. 2006 Mar-Apr; 24(2):176-8.
    View in: PubMed
    Score: 0.193
  2. Interleukin-10 genotypes are associated with systemic sclerosis and influence disease-associated autoimmune responses. Genes Immun. 2005 May; 6(3):274-8.
    View in: PubMed
    Score: 0.182
  3. IgG antibodies to human cytomegalovirus late protein UL94 in patients with systemic sclerosis. Autoimmunity. 2004 May; 37(3):241-4.
    View in: PubMed
    Score: 0.170
  4. Ethnic differences in cytotoxic T lymphocyte associated antigen 4 genotype associations with systemic sclerosis. J Rheumatol. 2004 Jan; 31(1):85-7.
    View in: PubMed
    Score: 0.166
  5. Immunoglobulin GM genes and IgG antibodies to cytomegalovirus in patients with systemic sclerosis. Clin Exp Rheumatol. 2004 Jan-Feb; 22(3 Suppl 33):S35-7.
    View in: PubMed
    Score: 0.166
  6. A profibrotic polymorphism (of TGFbeta1) in systemic sclerosis. Ann Rheum Dis. 2002 Aug; 61(8):671-2.
    View in: PubMed
    Score: 0.150
  7. Cytochrome P2 polymorphisms and susceptibility to scleroderma: comment on the article by Povey et al. Arthritis Rheum. 2001 Nov; 44(11):2705-6.
    View in: PubMed
    Score: 0.143
  8. Anti-fibrillin-1 autoantibodies in systemic sclerosis are GM and KM allotype-restricted. Exp Clin Immunogenet. 2001; 18(3):123-9.
    View in: PubMed
    Score: 0.135
  9. TNF-alpha and TNF-beta gene polymorphisms in systemic sclerosis. Hum Immunol. 1999 Nov; 60(11):1128-30.
    View in: PubMed
    Score: 0.124
  10. Human cytomegalovirus and the vasculopathies of autoimmune diseases (especially scleroderma), allograft rejection, and coronary restenosis. Arthritis Rheum. 1998 Jan; 41(1):10-5.
    View in: PubMed
    Score: 0.110
  11. Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: analytical accuracy and clinical associations in systemic sclerosis. Arthritis Rheum. 2005 Aug; 52(8):2425-32.
    View in: PubMed
    Score: 0.046
  12. HLA class II alleles in systemic sclerosis patients with anti-RNA polymerase I/III antibody: associations with subunit reactivities. J Rheumatol. 2003 Nov; 30(11):2392-7.
    View in: PubMed
    Score: 0.041
  13. Solvent oriented hobbies and the risk of systemic sclerosis. J Rheumatol. 1999 Nov; 26(11):2369-72.
    View in: PubMed
    Score: 0.031
  14. Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin-1, in patients with scleroderma and other connective tissue diseases. J Immunol. 1999 Jul 15; 163(2):1066-72.
    View in: PubMed
    Score: 0.030
  15. Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum. 1998 Jun; 41(6):1111-8.
    View in: PubMed
    Score: 0.028
  16. Immunoglobulin allotype gene polymorphisms in systemic sclerosis: interactive effect of MHC class II and KM genes on anticentromere antibody production. Ann Rheum Dis. 1998 Jun; 57(6):366-70.
    View in: PubMed
    Score: 0.028
  17. Association of immunoglobulin Km and Gm allotypes with specific antinuclear antibodies and disease susceptibility among connective tissue disease patients. Arthritis Rheum. 1991 Apr; 34(4):453-8.
    View in: PubMed
    Score: 0.017
  18. Familial clustering of scleroderma spectrum disease. Am J Med. 1988 Jun; 84(6):1023-32.
    View in: PubMed
    Score: 0.014
  19. Anticentromere antibody and immunoglobulin allotypes in scleroderma. Arch Dermatol. 1985 Mar; 121(3):339-44.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.